Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cytokines in sickle cell disease.

Anil Pathare1, Salam Al Kindi, Shahina Daar

  • 1Department of Hematology, College of Medicine, Sultan Qaboos University, Muscat, Sultanate of Oman. avp16@hotmail.com

Hematology (Amsterdam, Netherlands)
|October 8, 2003
PubMed
Summary

Sickle cell disease involves activated blood cells and endothelium, leading to cell adhesion and vasoocclusion. This complex cellular activation underlies the painful vasoocclusive crises characteristic of sickle cell disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dynamic OGTT-Derived Indices Outperform Fasting HOMA-2 for Detecting Dysglycemia in Transfusion-Dependent β-Thalassemia.

Mediterranean journal of hematology and infectious diseases·2026
Same author

Antiviral Therapy and Hepatitis B Reactivation Outcomes in Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitors: A Retrospective Cohort Study.

Oman medical journal·2026
Same author

A Descriptive Preanalytical Survey of Procedures Followed for the Screening of Glucose Dysregulation in Thalassemia Centers: Implications for Clinical Practice and Call for Harmonization.

Mediterranean journal of hematology and infectious diseases·2026
Same author

Concordance Rate of Fasting Plasma Glucose (PG) and 2-hour PG post Oral Glucose Tolerance Test (OGTT) in Patients with New Diagnosis of Thalassemia-Related Diabetes Mellitus (Th-RDM): Implications for Clinical Practice.

Mediterranean journal of hematology and infectious diseases·2026
Same author

Outcomes of autologous stem cell transplantation in patients with multiple sclerosis: A United Arab Emirates experience.

Multiple sclerosis and related disorders·2025
Same author

Post-Load Plasma Glucose Increase (PG-gap) as a Risk Factor for Developing Dysglycemia in Patients with Transfusion-Dependent β-Thalassemia (β-TDT): Retrospective Analysis over 8 Years.

Mediterranean journal of hematology and infectious diseases·2025

Area of Science:

  • Hematology
  • Vascular Biology
  • Immunology

Background:

  • Sickle red blood cells express adhesion molecules, promoting binding to endothelial cells.
  • Activated sickle monocytes, polymorphonuclear leukocytes (PMNs), and platelets contribute to endothelial activation and inflammation.
  • Endothelial cell activation results in loss of vascular integrity and a prothrombotic state.

Purpose of the Study:

  • To elucidate the molecular mechanisms of cellular activation in sickle cell disease.
  • To understand the role of cell-cell interactions in the pathogenesis of vasoocclusion.

Main Methods:

  • Analysis of adhesion molecule expression on sickle red cells, monocytes, PMNs, and platelets.
  • Assessment of cytokine release and endothelial cell activation markers.

Related Experiment Videos

  • Investigation of cell-aggregate formation and endothelial-extracellular matrix interactions.
  • Main Results:

    • Sickle cells, monocytes, PMNs, and platelets exhibit increased expression of adhesion molecules and activation markers.
    • Proinflammatory cytokines (TNF-alpha, IL-1beta) are elevated.
    • Activated endothelial cells upregulate adhesion molecules, HLA molecules, and expose extracellular matrix proteins, facilitating vasoocclusion.

    Conclusions:

    • Multiple cellular interactions and activation pathways contribute to endothelial dysfunction in sickle cell disease.
    • These processes culminate in vasoocclusion and tissue ischemia, forming the basis of vasoocclusive crisis.